A recent Department of Health and Human Services Office of Inspector General audit report on 2013 inpatient rehabilitation facility stays “is a prime example” of the AHA’s ongoing concerns with OIG audit reports targeting potential Medicare overpayments to hospitals, the association told the agency today. “[W]e believe that the inability of IRFs to challenge the OIG’s findings (first directly with the OIG at the end of the audit and then through the appeals process) before the report was issued allowed the OIG grossly to overestimate the number of IRF claims that should not have been paid as well as the total overpayment for 2013,” AHA wrote. “…The AHA is confident that a very large proportion of the 175 claims the OIG said should have been denied would have been reversed on appeal had the providers been able to challenge them. And the OIG’s sampling and extrapolation methodologies also may have been called into question.” Among other concerns, AHA said the report’s “errors may discourage Medicare beneficiaries from seeking needed and valuable IRF care, waste scarce IRF and government resources and unfairly damage IRFs’ reputations.” 

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…